{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T23:46:59Z","timestamp":1771458419818,"version":"3.50.1"},"reference-count":25,"publisher":"American Association of Psychiatric Pharmacists (AAPP)","issue":"1","license":[{"start":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T00:00:00Z","timestamp":1569283200000},"content-version":"vor","delay-in-days":631,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction:<\/jats:title>\n                  <jats:p>Dementia encompasses diseases of progressive memory loss and neurological alterations, including Alzheimer disease. Hypertension is one risk factor proposed for development of Alzheimer disease. The objective is to evaluate the current literature for use of diuretics in the prevention of dementia.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods:<\/jats:title>\n                  <jats:p>Literature was not considered if published before January 1, 2000, or after May 31, 2015. PubMed was used to locate sources. Four search terms were used to find data: Alzheimer disease, antihypertensive agents, diuretics, and dementia.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results:<\/jats:title>\n                  <jats:p>Four studies of efficacy of diuretic usage in the prevention against dementia met criteria. Potassium-sparing diuretics displayed risk reduction of Alzheimer disease and maintenance of cognitive function. Risk reduction was demonstrated when used alone (adjusted hazard ratio [aHR] 0.09, 95% confidence interval [CI] 0.01-0.41) as compared to use of other antihypertensives without potassium-sparing diuretics (aHR 0.76, 95% CI 0.49-1.15). Other antihypertensive drug classes did show some benefit, however. Diuretic and angiotensin receptor blocker users had a lower Alzheimer disease risk versus those with no antihypertensive use (hazard ratio 0.40, 95% CI 0.26-0.61) and (hazard ratio 0.37, 95% CI 0.19-0.72), respectively. Additionally, thiazide diuretics were also shown to reduce Alzheimer risk. Thiazide and potassium-sparing combination significantly reduced risk versus non-antihypertensive users (aHR 0.63, 95% CI 0.42-0.94).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion:<\/jats:title>\n                  <jats:p>Available research demonstrates an inverse association between diuretic use and the incident rate of dementia. Specifically, this has been found with thiazide and potassium-sparing diuretics when used alone or in combination. This review suggests that patients receiving diuretics for hypertension may receive an added neuroprotective effect.<\/jats:p>\n               <\/jats:sec>","DOI":"10.9740\/mhc.2018.01.033","type":"journal-article","created":{"date-parts":[[2018,1,4]],"date-time":"2018-01-04T17:40:46Z","timestamp":1515087646000},"page":"33-40","source":"Crossref","is-referenced-by-count":15,"title":["Diuretics: A possible keystone in upholding cognitive health"],"prefix":"10.9740","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4979-9768","authenticated-orcid":false,"given":"Tyler","family":"DeLoach","sequence":"first","affiliation":[{"name":"Position Title to Come, McWhorter School of Pharmacy, Samford University, Birmingham, Alabama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9709-5741","authenticated-orcid":false,"given":"Jennifer","family":"Beall","sequence":"first","affiliation":[{"name":"(Corresponding author) Associate Professor of Pharmacy Practice, McWhorter School of Pharmacy, Birmingham, Alabama, jwbeall@samford.edu"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4719","reference":[{"issue":"12 Suppl","key":"2020060307270988100_i2168-9709-8-1-33-b01","first-page":"5","article-title":"APA Work Group on Alzheimer's Disease and other Dementias","volume":"164","year":"2007","journal-title":"Am J Psychiatry"},{"key":"2020060307270988100_i2168-9709-8-1-33-b02","article-title":"Dementia","author":"Seeley","year":"2014","journal-title":"Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson J, Loscalzo J, et al, editors. Harrison's principles of internal medicine. 19 ed"},{"issue":"19","key":"2020060307270988100_i2168-9709-8-1-33-b03","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1212\/WNL.0b013e31828726f5","article-title":"Alzheimer disease in the United States (2010-2050) estimated using the 2010 census","volume":"80","author":"Hebert","year":"2013","journal-title":"Neurology"},{"issue":"11","key":"2020060307270988100_i2168-9709-8-1-33-b04","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jalz.2015.02.003","article-title":"Alzheimer's disease facts and figures","volume":"3","author":"Alzheimer's Association","year":"2015","journal-title":"Alzheimers Dement"},{"issue":"6","key":"2020060307270988100_i2168-9709-8-1-33-b05","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/(SICI)1099-1166(199906)14:6<481::AID-GPS959>3.0.CO;2-5","article-title":"Rates of dementia in three ethnoracial groups","volume":"14","author":"Gurland","year":"1999","journal-title":"Int J Geriatr Psychiatry"},{"key":"2020060307270988100_i2168-9709-8-1-33-b06","unstructured":"Erol \n              R.\n            \n          \n          Dawn, Brooker R, Peel E, Brooker D. Women and dementia: A global research review. 2015Jun. Availablefrom: http:\/\/www.researchgate.net\/publication\/277865960_Women_and_Dementia_A_global_research_review"},{"issue":"6","key":"2020060307270988100_i2168-9709-8-1-33-b07","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.jalz.2014.06.015","article-title":"APOE \u025b4: the most prevalent yet understudied risk factor for Alzheimer's disease","volume":"10","author":"Michaelson","year":"2014","journal-title":"Alzheimers Dement"},{"issue":"6","key":"2020060307270988100_i2168-9709-8-1-33-b08","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.amjhyper.2004.02.014","article-title":"Silent cerebral white matter lesions and cognitive function in middle-aged essential hypertensive patients","volume":"17","author":"Sierra","year":"2004","journal-title":"Am J Hypertens"},{"issue":"8","key":"2020060307270988100_i2168-9709-8-1-33-b09","doi-asserted-by":"publisher","first-page":"771","DOI":"10.7150\/ijms.8147","article-title":"Impaired cognitive executive dysfunction in adult treated hypertensives with a confirmed diagnosis of poorly controlled blood pressure","volume":"11","author":"Spinelli","year":"2014","journal-title":"Int J Med Sci"},{"issue":"10","key":"2020060307270988100_i2168-9709-8-1-33-b10","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1001\/jamaneurol.2014.1646","article-title":"Midlife hypertension and 20-year cognitive change: the atherosclerosis risk in communities neurocognitive study","volume":"17","author":"Gottesman","year":"2014","journal-title":"JAMA Neurol"},{"issue":"1","key":"2020060307270988100_i2168-9709-8-1-33-b11","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/01.wad.0000201848.67954.7d","article-title":"Low serum potassium in mid life associated with decreased cerebrospinal fluid Abeta42 in late life","volume":"20","author":"Mielke","year":"2006","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"1","key":"2020060307270988100_i2168-9709-8-1-33-b12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1161\/01.HYP.24.1.77","article-title":"Potassium inhibits free radical formation","volume":"24","author":"McCabe","year":"1994","journal-title":"Hypertension"},{"issue":"12","key":"2020060307270988100_i2168-9709-8-1-33-b13","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1016\/j.bbadis.2015.09.009","article-title":"The increased potassium intake improves cognitive performance and attenuates histopathological markers in a model of Alzheimer's disease","volume":"1852","author":"Cisternas","year":"2015","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"2020060307270988100_i2168-9709-8-1-33-b14","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1001\/archneur.63.5.noc60013","article-title":"Antihypertensive medication use and incident Alzheimer disease: the Cache County Study","volume":"63","author":"Khachaturian","year":"2006","journal-title":"Arch Neurol"},{"issue":"3","key":"2020060307270988100_i2168-9709-8-1-33-b15","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.jalz.2011.03.010","article-title":"Diuretic use is associated with better learning and memory in older adults in the Ginkgo Evaluation of Memory Study","volume":"8","author":"Yasar","year":"2012","journal-title":"Alzheimers Dement"},{"issue":"10","key":"2020060307270988100_i2168-9709-8-1-33-b16","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1212\/WNL.0b013e3182a35228","article-title":"Antihypertensive drugs decrease risk of Alzheimer disease: Ginkgo Evaluation of Memory Study","volume":"81","author":"Yasar","year":"2013","journal-title":"Neurology"},{"issue":"11","key":"2020060307270988100_i2168-9709-8-1-33-b17","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1016\/j.neurobiolaging.2014.05.002","article-title":"Use of diuretics is associated with reduced risk of Alzheimer's disease: the Cache County Study","volume":"35","author":"Chuang","year":"2014","journal-title":"Neurobiol Aging"},{"key":"2020060307270988100_i2168-9709-8-1-33-b18","article-title":"Regulation of renal function and vascular volume","author":"Reilly","year":"2011","journal-title":"Goodman & Gilman's the pharmacological basis of therapeutics. 12 ed"},{"key":"2020060307270988100_i2168-9709-8-1-33-b19","article-title":"Free radicals & antioxidant nutrients","author":"Bender","year":"2015","journal-title":"Rodwell VW, Bender DA, Botham KM, Kennelly PJ, Weil P, Victor W, et al, editors. Harper's illustrated biochemistry. 30 ed"},{"issue":"3-4","key":"2020060307270988100_i2168-9709-8-1-33-b20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/0891-0618(96)00148-2","article-title":"Nitric oxide neurotoxicity","volume":"10","author":"Dawson","year":"1996","journal-title":"J Chem Neuroanat"},{"issue":"21","key":"2020060307270988100_i2168-9709-8-1-33-b21","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.2174\/1568026615666150610143234","article-title":"The role of uric acid and methyl derivatives in the prevention of age-related neurodegenerative disorders","volume":"15","author":"Cutler","year":"2015","journal-title":"Curr Top Med Chem"},{"issue":"12","key":"2020060307270988100_i2168-9709-8-1-33-b22","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1016\/S0028-3908(99)00071-4","article-title":"Role of cyclic GMP in glutamate neurotoxicity in primary cultures of cerebellar neurons","volume":"38","author":"Montoliu","year":"1999","journal-title":"Neuropharmacology"},{"issue":"2","key":"2020060307270988100_i2168-9709-8-1-33-b23","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1523\/JNEUROSCI.07-02-00357.1987","article-title":"Glutamate neurotoxicity in cortical cell culture","volume":"7","author":"Choi","year":"1987","journal-title":"J Neurosci"},{"issue":"14","key":"2020060307270988100_i2168-9709-8-1-33-b24","doi-asserted-by":"crossref","first-page":"6368","DOI":"10.1073\/pnas.88.14.6368","article-title":"Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures","volume":"88","author":"Dawson","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2020060307270988100_i2168-9709-8-1-33-b25","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"}],"container-title":["Mental Health Clinician"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/mhc\/article-pdf\/8\/1\/33\/2095058\/mhc_2018_01_033.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/mhc\/article-pdf\/8\/1\/33\/2095058\/mhc_2018_01_033.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T16:23:20Z","timestamp":1731687800000},"score":1,"resource":{"primary":{"URL":"https:\/\/mhc.kglmeridian.com\/view\/journals\/mhcl\/8\/1\/article-p33.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1,1]]}},"URL":"https:\/\/doi.org\/10.9740\/mhc.2018.01.033","relation":{},"ISSN":["2168-9709"],"issn-type":[{"value":"2168-9709","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,1]]}}}